Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
Hematologic Oncology Update
00:00
Case 1: 80-year-old DLBCL with ICANS treated successfully
Dr Lunning reviews an 80-year-old with DLBCL who developed CRS then progressive ICANS treated with anakinra and IT therapy.
Play episode from 36:20
Transcript
